BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 128026)

  • 41. Effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and 5,7-dihydroxytryptamine on the hippocampal kindling effect in rats.
    Araki H; Aihara H; Watanabe S; Yamamoto T; Ueki S
    Jpn J Pharmacol; 1983 Dec; 33(6):1177-82. PubMed ID: 6230476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Hemerocallis flava on motor activity and the concentration of central monoamines and its metabolites in rats.
    Hsieh MT; Ho YF; Peng WH; Wu CR; Chen CF
    J Ethnopharmacol; 1996 Jun; 52(2):71-6. PubMed ID: 8735450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of monoamine neural systems in L-dihydroxyphenylalanine-stimulated activity.
    Hollister AS; Breese GR; Mueller RA
    J Pharmacol Exp Ther; 1979 Jan; 208(1):37-43. PubMed ID: 759613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The behavioral effects of the stereoisomers of 4-methylaminorex, a psychostimulant, in the rat.
    Batsche K; Ashby CR; Lee C; Schwartz J; Wang RY
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1029-39. PubMed ID: 7912274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine.
    Breese GR; Cooper BR; Mueller RA
    Br J Pharmacol; 1974 Oct; 52(2):307-314. PubMed ID: 4155993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation by serotonin of glutamate-induced lethality in mice.
    Kamei J; Igarashi H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):167-84. PubMed ID: 1839809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Motor effects of serotonin in the central nervous system.
    Gerson SC; Baldessarini RJ
    Life Sci; 1980 Oct; 27(16):1435-51. PubMed ID: 6160367
    [No Abstract]   [Full Text] [Related]  

  • 48. Central action of narcotic analgesics. VII. The role of serotonin in the development of morphine tolerance in the locomotor activity test in mice and rats.
    Langwiński R; Fidecka S
    Pol J Pharmacol Pharm; 1981; 33(2):193-202. PubMed ID: 6458804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
    Svensson K; Johansson AM; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):234-45. PubMed ID: 2880302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maternal aggression in mice: effects of treatments with PCPA, 5-HTP and 5-HT receptor antagonists.
    Ieni JR; Thurmond JB
    Eur J Pharmacol; 1985 May; 111(2):211-20. PubMed ID: 3160594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Withdrawal from repeated administration of a low dose of reserpine induced opposing adaptive changes in the noradrenaline and serotonin system function: a behavioral and neurochemical ex vivo and in vivo studies in the rat.
    Antkiewicz-Michaluk L; Wąsik A; Możdżeń E; Romańska I; Michaluk J
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():146-54. PubMed ID: 25445479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors.
    Wachtel H; Schneider HH
    Neuropharmacology; 1986 Oct; 25(10):1119-26. PubMed ID: 2946976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological analysis of the neurotransmitter mechanisms regulating phenylethanolamine N-methyltransferase in the adrenal gland.
    Lima L; Sourkes TL
    Biochem Pharmacol; 1986 Nov; 35(22):3965-9. PubMed ID: 2946301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Locomotor effects of nitrous oxide in mice: requirement of newly-synthesized and main intraneuronal storage pools of dopamine.
    Dorris RL; Truong V
    J Pharm Pharmacol; 1993 Apr; 45(4):315-6. PubMed ID: 8098374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of pentylenetetrazol and trimethadione on the metabolism of serotonin in brain and its relation to the anticonvulsant action of trimethadione.
    Diaz PM
    Neuropharmacology; 1974 Jul; 13(7):615-21. PubMed ID: 4280025
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug-induced brain monoamine depletion and its behavioral correlates in Caiman sclerops.
    Doshi E; Huggins SE
    Comp Biochem Physiol C Comp Pharmacol; 1977; 57(2):153-7. PubMed ID: 20272
    [No Abstract]   [Full Text] [Related]  

  • 59. Monoamine mediation of the morphine-induced activation of mice.
    Carroll BJ; Sharp PT
    Br J Pharmacol; 1972 Sep; 46(1):124-39. PubMed ID: 4263794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain.
    Davis JN; Carlsson A
    J Neurochem; 1973 Oct; 21(4):783-90. PubMed ID: 4148239
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.